Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill hopes to tame ulcerative colitis in older adults

NCT ID NCT07243639

Recruiting now Disease control Sponsor: Showa Inan General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study is testing a new oral drug called etrasimod in 30 elderly patients with active ulcerative colitis. Researchers will track how many patients achieve remission after 4 weeks and look for improvements in the gut lining after a year. The goal is to see if the drug is safe and effective for older adults, who often have more health challenges.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
etrasimod
What this could lead to
If successful, this could provide a new oral treatment option for elderly patients with ulcerative colitis, potentially improving disease control and quality of life.
What could go wrong
This is a small, early-phase study with only 30 participants, so results may not apply broadly. The drug may cause side effects or fail to show clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ULCERATIVE COLITIS (DISORDER)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Showa Inan General Hospital

    RECRUITING

    Komagane, Nagano, 399-4117, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.